SEC Comment Letter for ENvue Medical, Inc. (FEED) (CIK 0001326706) (FEED) — Jan 28, 2020
ENvue Medical, Inc. (FEED) (CIK 0001326706)
Date: Jan. 28, 2020 · CIK: 0001326706 · Accession: 0000000000-20-000720
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236000
Letter
January 27, 2020 Brian Murphy Chief Executive Officer NanoVibronix, Inc. 525 Executive Blvd. Elmsford, New York Re:NanoVibronix, Inc. Registration Statement on Form S-3 Filed January 22, 2020 File No. 333-236000 Dear Mr. Murphy: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jayun Koo, Esq.
Show Raw Text
January 27, 2020
Brian Murphy
Chief Executive Officer
NanoVibronix, Inc.
525 Executive Blvd.
Elmsford, New York
Re:NanoVibronix, Inc.
Registration Statement on Form S-3
Filed January 22, 2020
File No. 333-236000
Dear Mr. Murphy:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jayun Koo, Esq.